STAP-2-Derived Peptide Suppresses TCR-Mediated Signals to Initiate Immune Responses.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
01 09 2023
Historique:
received: 28 12 2022
accepted: 20 06 2023
medline: 23 8 2023
pubmed: 7 7 2023
entrez: 7 7 2023
Statut: ppublish

Résumé

Signal-transducing adaptor protein-2 (STAP-2) is an adaptor protein that contains pleckstrin and Src homology 2-like domains, as well as a proline-rich region in its C-terminal region. Our previous study demonstrated that STAP-2 positively regulates TCR signaling by associating with TCR-proximal CD3ζ ITAMs and the lymphocyte-specific protein tyrosine kinase. In this study, we identify the STAP-2 interacting regions of CD3ζ ITAMs and show that the STAP-2-derived synthetic peptide (iSP2) directly interacts with the ITAM sequence and blocks the interactions between STAP-2 and CD3ζ ITAMs. Cell-penetrating iSP2 was delivered into human and murine T cells. iSP2 suppressed cell proliferation and TCR-induced IL-2 production. Importantly, iSP2 treatment suppressed TCR-mediated activation of naive CD4+ T cells and decreased immune responses in CD4+ T cell-mediated experimental autoimmune encephalomyelitis. It is likely that iSP2 is a novel immunomodulatory tool that modulates STAP-2-mediated activation of TCR signaling and represses the progression of autoimmune diseases.

Identifiants

pubmed: 37417746
pii: 265750
doi: 10.4049/jimmunol.2200942
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
Receptors, Antigen, T-Cell 0
STAP2 protein, human 0
Peptide Fragments 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

755-766

Informations de copyright

Copyright © 2023 by The American Association of Immunologists, Inc.

Auteurs

Yuto Sasaki (Y)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

Kodai Saitoh (K)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

Kota Kagohashi (K)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

Toyoyuki Ose (T)

Faculty of Advanced Life Science, Hokkaido University, Sapporo, Japan.

Shoya Kawahara (S)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

Yuichi Kitai (Y)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

Ryuta Muromoto (R)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

Yuichi Sekine (Y)

Department of Cell Biology, Kyoto Pharmaceutical University, Kyoto, Japan.

Michiko Ichii (M)

Department of Hematology and Oncology, Osaka University Graduate School of Medicine, Osaka, Japan.

Akihiko Yoshimura (A)

Department of Microbiology and Immunology, Keio University School of Medicine, Tokyo, Japan.

Kenji Oritani (K)

Department of Hematology, International University of Health and Welfare, Narita, Japan.

Jun-Ichi Kashiwakura (JI)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.
Department of Life Science, Faculty of Pharmaceutical Sciences, Hokkaido University of Science, Sapporo, Japan.

Tadashi Matsuda (T)

Department of Immunology, Graduate School of Pharmaceutical Sciences, Hokkaido University, Sapporo, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH